Cargando…

Treatment of Lipid Disorders in Cardiovascular Patients

Detalles Bibliográficos
Autor principal:	Williams, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2003
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169133/ https://www.ncbi.nlm.nih.gov/pubmed/30302082

Ejemplares similares

Racial Differences in Blood Lipids Lead to Underestimation of Cardiovascular Risk in Black Women in a Nested observational Study
por: McIntosh, Mark S., et al.
Publicado: (2013)

Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey
por: Eliasson, Björn, et al.
Publicado: (2019)

Implications of True and Perceived Treatment Burden on Cardiovascular Medication Use
por: Sussman, Jeremy B., et al.
Publicado: (2017)

Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
por: Delbaere, Quentin, et al.
Publicado: (2023)

The Role of Lipids in the Development of Atherosclerosis and Coronary Heart Disease: Guidelines for Diagnosis and Treatment
por: Blaton, Victor
Publicado: (2003)

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2021)

Roles for a lipid phosphatase in the activation of its opposing lipid kinase
por: Strunk, Bethany S., et al.
Publicado: (2020)

Patient Perception of Cardiovascular Risk in Rheumatoid Arthritis
por: Banerjee, Shubhasree, et al.
Publicado: (2020)

Prediction of 12-Week Remission by Psychopharmacological Treatment Step in Patients With Depressive Disorders
por: Jin, Yun-Tae, et al.
Publicado: (2022)

Weight Bias Internalization and Eating Disorder Psychopathology in Treatment-Seeking Patients with Obesity
por: Calugi, Simona, et al.
Publicado: (2023)

Strategy of Prevention of Cardiovascular Disease
por: Kovács, Gábor L., et al.
Publicado: (2003)

Controlling Lipids AIDS in the Prevention of Type 2 Diabetes, Hypertension, and Cardiovascular Diseases
por: Nayak, Shivananda B., et al.
Publicado: (2017)

An intramolecular interaction within the lipid kinase Fab1 regulates cellular phosphatidylinositol 3,5-bisphosphate lipid levels
por: Lang, Michael J., et al.
Publicado: (2017)

The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Deodhar, Atul, et al.
Publicado: (2016)

Pre-treatment with compound Danshen dripping pills prevents lipid infusion-induced microvascular dysfunction in mice
por: Zhang, Yanda, et al.
Publicado: (2020)

Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder and/or Tourette's Disorder with Clonidine Extended Release
por: Joo, Sung Woo, et al.
Publicado: (2018)

Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder
por: Bossie, Cynthia A., et al.
Publicado: (2017)

Use and knowledge of contraceptive methods by patients in two substance use disorders treatment centers in Paris
por: Clergue-Duval, Virgile, et al.
Publicado: (2017)

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder
por: Fu, Dong-Jing, et al.
Publicado: (2016)

Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
por: Karameh, Wael Karameh, et al.
Publicado: (2015)

Genetics of Cardiovascular Disease
por: Stavljenic-Rukavina, Ana
Publicado: (2003)

Optimization of Lipid-Lowering Therapy for High Cardiovascular Risk Patients Through Electronic Medical Record Reporting and Pharmacist Evaluation
por: Chen, Kaylee, et al.
Publicado: (2020)

Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting
por: Sweeney, Mary M., et al.
Publicado: (2022)

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting
por: Lee, Kyung Ho, et al.
Publicado: (2023)

Body mass index impacts the choice of lipid‐lowering treatment with no correlation to blood cholesterol – Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)
por: Ferrières, Jean, et al.
Publicado: (2018)

Cardiovascular Disorders Risk Factors in Different Industries of Iran
por: Assadi, Seyedeh Negar
Publicado: (2013)

Blood Culture–Negative Cardiovascular Infection in a Patient With Multiple Sclerosis
por: Melenotte, Cléa, et al.
Publicado: (2019)

Trends in Cardiovascular Complications and Mortality among Patients with Diabetes in South Korea
por: Park, Jung Hwan, et al.
Publicado: (2021)

Patient perception of voxelotor treatment benefit in sickle cell disease
por: Idowu, Modupe, et al.
Publicado: (2022)

Open-Label Study of Duloxetine for the Treatment of Obsessive-Compulsive Disorder
por: Dougherty, Darin D., et al.
Publicado: (2015)

Oriented mentalization-based treatment for borderline personality disorder patients: preliminary results at Camposampiero Mental Health Center
por: Carrera, Stefano, et al.
Publicado: (2018)

Evaluation of severe hypoglycemia and common mental disorders in patients receiving insulin analogues for treatment of type 1 diabetes
por: Berlanda, Gabriela, et al.
Publicado: (2020)

Diabetes Mellitus and Cardiovascular Disease
por: Aganovic, Izet
Publicado: (2003)

Rational Diagnosis of Cardiovascular Disease
por: Müller, Mathias M., et al.
Publicado: (2003)

Atherothrombosis: Pathogenesis of Cardiovascular Disease
por: Mojca, Stegnar
Publicado: (2003)

Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders
por: Nebhinani, Naresh, et al.
Publicado: (2022)

Glucose metabolism in cardiovascular surgery
por: Lazzeri, C, et al.
Publicado: (2010)

Psychological disorders in patients with chronic constipation
por: Hosseinzadeh, Sahar Tahbaz, et al.
Publicado: (2011)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_undm325i8tadkd7c4dr8m75tqq